Genetic silencing of CASP suppressed the proliferation and migration of colorectal cancer (CRC) cells, while its overexpression enhanced tumor growth and metastatic potential both <i>in vitro</i> and <i>in vivo</i>. The gene discussed is CUX1; the disease is colorectal carcinoma.